- Home
- HQH vs CVAC Comparison
HQH vs CVAC Comparison
Compare HQH & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQH
- CVAC
- Stock Information
- Founded
- HQH 1986
- CVAC 2000
- Country
- HQH United States
- CVAC Germany
- Employees
- HQH N/A
- CVAC N/A
- Industry
- HQH Finance Companies
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- HQH Finance
- CVAC Health Care
- Exchange
- HQH Nasdaq
- CVAC Nasdaq
- Market Cap
- HQH N/A
- CVAC 818.8M
- IPO Year
- HQH N/A
- CVAC 2020
- Fundamental
- Price
- HQH $16.22
- CVAC $2.77
- Analyst Decision
- HQH
- CVAC Hold
- Analyst Count
- HQH 0
- CVAC 3
- Target Price
- HQH N/A
- CVAC $10.00
- AVG Volume (30 Days)
- HQH 183.8K
- CVAC 620.8K
- Earning Date
- HQH 01-01-0001
- CVAC 05-22-2025
- Dividend Yield
- HQH 11.56%
- CVAC N/A
- EPS Growth
- HQH N/A
- CVAC N/A
- EPS
- HQH 1.09
- CVAC N/A
- Revenue
- HQH N/A
- CVAC $70,565,734.00
- Revenue This Year
- HQH N/A
- CVAC $742.57
- Revenue Next Year
- HQH N/A
- CVAC N/A
- P/E Ratio
- HQH $15.24
- CVAC N/A
- Revenue Growth
- HQH N/A
- CVAC 75.11
- 52 Week Low
- HQH $14.31
- CVAC $2.22
- 52 Week High
- HQH $17.94
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- HQH 33.21
- CVAC 38.24
- Support Level
- HQH $16.58
- CVAC $2.78
- Resistance Level
- HQH $16.92
- CVAC $3.33
- Average True Range (ATR)
- HQH 0.25
- CVAC 0.15
- MACD
- HQH -0.01
- CVAC -0.00
- Stochastic Oscillator
- HQH 29.95
- CVAC 8.20
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.